FDA Closes Class I Recall of Victory Medical Center Pharmacy Glutathione Vials

The agency considers the recall carried out; the product remains identified by lot numbers and use-by date.

2 reports on this incident · first at Aug 25, 2026, 5:46 p.m. ET

By AI ReporterWritten Aug 25, 2026, 5:55 p.m. ET

Developing · checked 4h ago

This recall is open. The agency updates its record as an action is expanded, reclassified or terminated, and this page is rewritten when it does.

We last searched for new coverage of this at Aug 25, 2026, 4:09 p.m. ET — checked 4h ago.

The U.S. Food and Drug Administration has closed the recall of glutathione vials distributed by of , Texas, according to the agency's enforcement report dated August 19, 2026 (recall number ). The closure means the FDA considers the recall carried out. The recall, initiated July 1, 2026, covers Glutathione (MDV), 200 mg/mL, 30 mL vials, each mL containing glutathione 200 mg, ascorbic acid 20 mg, benzyl alcohol 1.5%, sodium hydroxide (pH adjust) in sterile water for injection. The affected lots are #1984345, #1980571, and #1981940, with a use-before date of 08/27/2026. The FDA classified the action as , its most serious category, used where there is a reasonable probability that using the product will cause serious harm or death. The reason for the recall was microbial contamination of sterile products; out-of-specification results were obtained for bacterial endotoxin. The FDA's database records no other enforcement action by this firm. Anyone still holding product from these lots should check the label and follow the agency's guidance.

Earlier reports

Aug 25, 2026, 5:46 p.m. ETFirst report
FDA Class I Recall: Victory Medical Center Pharmacy Glutathione Vials
On August 19, 2026, the FDA posted an enforcement report for a Class I recall initiated by Victory Medical Center Pharmacy (Austin, TX) on July 1, 2026. The recall covers Glutathione (MDV), 200 mg/mL, 30 mL vials, lot numbers 1984345, 1980571, and 1981940, with a use-by date of 08/27/2026. The reason given is "Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin." The recall is ongoing and distributed nationwide.
Class I is the FDA's most serious category, used when there is a reasonable probability that using the product will cause serious harm or death. The FDA enforcement report lists 91 units affected. The product is a compounded sterile prescription drug administered via intravenous or intramuscular injection, according to product information from Empower Pharmacy and TrimRx.
The FDA database records no other enforcement actions for this firm. The recall number is D-0772-2026.

Was this report accurate and useful?

Sources

Revision history

Version 125 Aug 2026, 21:46current
First published.
Version 125 Aug 2026, 21:55current
First published.

How we work

This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.

Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.

Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.

None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.